Contact Us: | Toll Free No: 888 225 2950 | Phone: +1 407 996 9630 | Fax: +1 407 996 9631
Contact Us

FAQ

Q?

Where is MEDITE’s corporate headquarters?

A.

MEDITE's corporate address is 4203 SW 34th Street, Orlando, FL 32811

 

Q?

What does MEDITE do?

A.

MEDITE's only focus is on innovative solutions for cancer diagnostics. The company is a leading developer and manufacturer of innovative, high-quality equipment and supplies for histology, pathology and cytology laboratories. The Company is also engaged in the design, development, and commercialization of cost-effective cancer screening systems and Biomarkers to assist in the early detection of cancer.

 

Q?

Where can I find the latest financial reports and news releases?

A.

You can find our filings at www.sec.gov and on our website sub menu "News".

 

Q?

When is MEDITE’s fiscal year-end?

A.

MEDITE's fiscal year-end is December 31st.

Q?

Who are MEDITE’s Executive Officers?

A.

Michaela Ott, Chief Executive Officer
Michael Ott, President and Chief Operating Officer
Robert McCullough, Chief Financial Officer

Q?

Who is on MEDITE’s Board of Directors?

A.

Michaela Ott, Chief Executive Officer of MEDITE
Michael Ott, President and Chief Operating Officer of MEDITE
Robert McCullough, Chief Financial Officer of MEDITE
John Abeles, M.D.
Alexander Milley
Augusto Ocana

Q?

How many people does MEDITE employ?

A.

MEDITE has approximately 70 employees worldwide.

 

Q?

Who are MEDITE’s independent auditors?

A.

LJ Soldinger Associates LLC ("LJSA") serves as MEDITE's independent registered public accounting firm.

 

Q?

What exchange does MEDITE trade on?

A.

MEDITE trades on the OTC QB under the ticker symbol MDIT.

 

Q?

Does MEDITE pay a dividend?

A.

MEDITE does not currently pay dividends.

 

Q?

Does MEDITE have a direct stock purchase plan?

A.

MEDITE does not have a direct stock purchase plan.

 

Q?

Who do I contact with questions about my stock certificates?

A.

Inquiries concerning the transfer of shares, change of address or lost certificates should be directed to:

Computershare Shareowner Services
199 Water Street, 26th Floor
New York, New York, 10038
Telephone Number: +1 (212) 805-7100

Q?

How many shares of MEDITE are outstanding?

A.

As of December 31st, 2014, there were 19,412,761 shares outstanding.

 

Q?

How can I get additional investor information on MEDITE?

A.

Investor inquiries can be directed to: Robert McCullough, Chief Financial Officer

 

Q?

How can I be added to the MEDITE email distribution list?

A.

Please fill out the contact form to be added to our investor distribution list.

 

 

Q?

When was MEDITE founded?

A.

MEDITE was founded in 1978 and acquired by Michaela and Michael Ott in 2006.  MEDITE became a publicly-traded company in the U.S. through a merger transaction with CytoCore, Inc., completed in April 2014.